Expert Rev Gastroenterol Hepatol. 2012;6(5):591-601. Limited research has been developed on the molecular basis of EGE and its pathophysiology is poorly known, with most of the available ...

Eosinophilic gastroenteritis (EGE) is characterized by dense eosinophilic inflammation of one or several digestive tract sections. The symptoms include abdominal pain, weight loss, vomiting and ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

The results demonstrate the safety and efficacy of Fasenra in the treatment of acute eosinophilic exacerbations in asthma and ...

Eosinophilic fasciitis (EF) is a rare subacute fibrosing disorder of unknown aetiology, characterised by thickening of the muscular fascia and subcutaneous tissue, leading to swelling of limbs and ...

Eupraxia Pharmaceuticals' shares rose after the clinical-stage biotechnology company reported positive data from its Eosinophilic Esophagitis program, which it believes underscore its DiffuSphere ...

Asthma and chronic obstructive pulmonary disease (COPD) are significant health challenges, with asthma affecting around ...

We present a case of a 34-year-old man with long-term diagnosis of eosinophilic oesophagitis (EoE) who did not achieve control of disease after multiple therapies including topical and systemic ...

Eupraxia Pharmaceuticals (EPRX)unveiled new pharmacokinetic, or PK data from its Phase 2a Eosinophilic Esophagitis, or EoE, program.

The publication of this infographic was sponsored by ADVENT, a non-promotional medical education program designed to advance ...

Topical corticosteroid treatment over 6 years is safe and efficacious for treating eosinophilic esophagitis. Long-term use of topical corticosteroids (tCS) is both safe and efficacious for treating ...

The first new treatment for asthma attacks in 50 years may be a “game-changer”, researchers say. Offering patients an ...